Latest filing published 18 Feb 2025 for BIOSYNEX, €14k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Elie FRAENCKEL in Biosynex, where the filings describe the role as board member. The record holds 19 filings, for trades running from 19 April 2021 to 14 February 2025.
Both buying and selling appear: 16 purchases worth €463k, against 2 sales worth €611. Taken together, the purchases exceed the sales by €463k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at no purchases and 2 sales.
The median purchase comes to €18k. On 8 out of 16 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 18 February 2025 came the latest disclosure, a transaction for €14k in Biosynex. The last insider purchase was made public on 14 February 2023, 1,341 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations